FDA accepts United Therapeutics NDA for ralinepag PAH treatment
United Therapeutics Corporation (Nasdaq: UTHR) announced that the U.S. Food and Drug Administration has accepted its New Drug Application for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
